Bikash Chatterjee of Pharmatech Associates discusses the reshoring trend, technologies and advances that could help deliver more manufacturing back to the U.S.
More robust solutions for single-use cold-chain containers made with polytetrafluoroethylene fluoropolymers may be less susceptible to failure and breakage.
Barcelona-based Grifols SA will acquire Talecris Biotherapeutics Holdings Corp. for $3.4 billion in cash and stock, expanding its U.S. market share for blood-plasma products.